D-1000 Docetaxel, >99%

Synonyms : [RP 56976]

Related Terms : [Taxotere]

  • Size
  • US $
  • £
  • ¥
  • 100 mg
  • 36
  • 33
  • 28
  • 5,500
  • Add to Cart
  • Out of stock
  • 250 mg
  • 59
  • 54
  • 46
  • 9,000
  • Add to Cart
  • Out of stock
  • 500 mg
  • 96
  • 88
  • 76
  • 14,600
  • Add to Cart
  • Out of stock
  • 1 g
  • 181
  • 166
  • 143
  • 27,500
  • Add to Cart
  • Out of stock
  • 2 g
  • 244
  • 224
  • 193
  • 37,000
  • Add to Cart
  • Out of stock
  • 5 g
  • 410
  • 377
  • 325
  • 62,200
  • Add to Cart
  • Out of stock
  • 10 g
  • 730
  • 672
  • 579
  • 110,800
  • Add to Cart
  • Out of stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Free Shipping and Handling to the U.S. and 32 Other Countries
  • M.W. 807.88
  • C43H53NO14
  • [114977-28-5]
  • M.I. 13: 3431
  • M.I. 14: 3397

Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 200 mg/mL; soluble in ethanol at 100 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility. Disposal: A.

Select Lot Number to view Certificate of Analysis

View the SDS for this product

  • More than 630 labs worldwide have purchased Docetaxel from LC Labs (either directly from us or from our many distributors, many of whom resell under their own labels).
  • Docetaxel, a semisynthetic analog of paclitaxel, shares the latter's mechanism of action: the promotion of microtubule assembly and inhibition of microtubule disassembly. This anti-mitotic behavior results in apoptosis of human leukemia HL-60 cells arrested at the M phase in the cell cycle. Pazdur, R., et al. "The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere)." Cancer Treat Rev. 19: 351-386 (1993). Hagisawa, S., et al. "Docetaxel-induced apoptosis in the mitotic phase: electron microscopic and cytochemical studies of human leukemia cells." Med Electron Microsc. 32: 167-174 (1999).
  • Docetaxel has exhibited significant antitumor activity against prostate cancer, metastatic breast cancer, gastric cancer, and others. Pienta, K.J. "Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer." Semin Oncol. 4: 3-7 (2001). Yoshida, K., et al. "Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer." Anticancer Res. 24: 1843-1851 (2004). Tabernero, J., et al. "A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer." Ann Oncol. 15: 1358-1365 (2004).
  • Docetaxel is the active ingredient in the drug product sold under the trade name Taxotere®. This drug is currently approved in at least one country for use in patients with Breast Cancer, Non Small Cell Lung Cancer, Hormone Refractory Prostrate Cancer, and many other conditions NOTE: THE DOCETAXEL SOLD BY LC LABORATORIES FOR RESEARCH IS NOT TAXOTERE®, AND IS NOT FOR HUMAN USE.

  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
88